ArticleOncotarget2017

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

Dmitry M Ponomarenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.